Switching among biologic therapies is common practice in patients with rheumatoid arthritis who have an inadequate response or intolerable adverse events. Evidence from observational studies and ...
Tolerability challenges have been identified with tumor necrosis factor (TNF) antagonist therapy in the treatment of rheumatoid arthritis ... including both non-biologic DMARDs such as MTX ...
Rheumatoid Arthritis Awareness Day 2025 is observed on February 2. Created in 2013 by the Rheumatoid Patient Foundation, it is to raise awareness around the chronic autoimmune disease. Rheumatoid ...
“Asthma and rheumatoid arthritis (RA) are both prevalent diseases ... oral corticosteroids, biologics and azathioprine. Ramonell and Wenzel called these findings that eight of nine patients ...
Rheumatoid arthritis (RA) is a chronic autoimmune condition that affects millions worldwide. According to the World Health Orgnization, 18 million people worldwide were living with the condition in ...
A link between rheumatoid arthritis and appendicitis has been investigated before, but newer research has not confirmed these findings. Rheumatoid arthritis is an autoimmune disease where the ...
KUALA LUMPUR, Jan 22 (Bernama) -- Five out of every 1,000 Malaysians are affected by Rheumatoid Arthritis (RA), a condition that causes chronic autoimmune ... which can be classified as conventional ...